Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit J Arsenault

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Journal of the American Heart Association|June 3, 2018
Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification TherapyMarjorie Boyer, Valérie Lévesque, Paul Poirier, et al.
European Journal of Clinical Investigation|August 13, 2010
Lipid assessment, metabolic syndrome and coronary heart disease riskBenoit J Arsenault, Jean-Pierre Després, Erik S G Stroes, et al.
Journal of Translational Medicine|January 31, 2023
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization studyEloi Gagnon, Patricia L Mitchell, Hasanga D Manikpurage, et al.
Circulation. Cardiovascular Genetics|April 8, 2014
Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohortBenoit J Arsenault, S Matthijs Boekholdt, Marie-Pierre Dubé, et al.
Iscience|July 17, 2023
Large-scale metabolomic profiling and incident non-alcoholic fatty liver diseaseEloi Gagnon, Hasanga D Manikpurage, Patricia L Mitchell, et al.
Journal of the American Heart Association|June 5, 2016
C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population StudyDiederik F van Wijk, S Matthijs Boekholdt, Benoit J Arsenault, et al.
European Heart Journal|October 20, 2007
Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population studyBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
Atherosclerosis|June 16, 2009
Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressureBenoit J Arsenault, Mélanie Côté, Amélie Cartier, et al.
Circulation. Genomic and Precision Medicine|March 7, 2025
Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization StudyEloi Gagnon, Dipender Gill, Dominique Chabot, et al.
Atherosclerosis|September 24, 2009
Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk studyBenoit J Arsenault, Jamal S Rana, Isabelle Lemieux, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Journal of the American Heart Association|June 3, 2018
Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification TherapyMarjorie Boyer, Valérie Lévesque, Paul Poirier, et al.
European Journal of Clinical Investigation|August 13, 2010
Lipid assessment, metabolic syndrome and coronary heart disease riskBenoit J Arsenault, Jean-Pierre Després, Erik S G Stroes, et al.
Journal of Translational Medicine|January 31, 2023
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization studyEloi Gagnon, Patricia L Mitchell, Hasanga D Manikpurage, et al.
Circulation. Cardiovascular Genetics|April 8, 2014
Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohortBenoit J Arsenault, S Matthijs Boekholdt, Marie-Pierre Dubé, et al.
Iscience|July 17, 2023
Large-scale metabolomic profiling and incident non-alcoholic fatty liver diseaseEloi Gagnon, Hasanga D Manikpurage, Patricia L Mitchell, et al.
Journal of the American Heart Association|June 5, 2016
C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population StudyDiederik F van Wijk, S Matthijs Boekholdt, Benoit J Arsenault, et al.
European Heart Journal|October 20, 2007
Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population studyBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
Atherosclerosis|June 16, 2009
Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressureBenoit J Arsenault, Mélanie Côté, Amélie Cartier, et al.
Circulation. Genomic and Precision Medicine|March 7, 2025
Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization StudyEloi Gagnon, Dipender Gill, Dominique Chabot, et al.
Atherosclerosis|September 24, 2009
Physical activity, the Framingham risk score and risk of coronary heart disease in men and women of the EPIC-Norfolk studyBenoit J Arsenault, Jamal S Rana, Isabelle Lemieux, et al.
Pageof 16